EVALUATION OF KNOWLEDGE, ATTITUDES, AND PRACTICES OF COMMUNITY PHARMACISTS TOWARD CELIAC DISEASE
Öz
Anahtar Kelimeler
Kaynakça
- 1. García Nieto, V.M. (2014). A history of celiac disease. Celiac Disease and Non-Celiac Gluten Sensitvity; Rodrigo, L., Peña, AS, Eds, 45-59.
- 2. Kara, A., Demirci, E., Ozmen, S. (2019). Evaluation of psychopathology and quality of life in children with celiac disease and their parents. Gazi Medical Journal, 30(1), 43-47. [CrossRef]
- 3. Fera, T., Cascio, B., Angelini, G., Martini, S., Guidetti, C.S. (2003). Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. European Journal of Gastroenterology and Hepatology, 15(12), 1287-1292.
- 4. Lebenthal, E., Shteyer, E., Branski, D. (2008). The changing clinical presentation of celiac disease. In Frontiers in Celiac Disease (Vol. 12, pp. 18-22). Karger Publishers.
- 5. Gottlieb, K., Dawson, J., Hussain, F., Murray, J.A. (2015). Development of drugs for celiac disease: Review of endpoints for Phase 2 and 3 trials. Gastroenterology Report, 3(2), 91-102. [CrossRef]
- 6. Rajput, M.S., Chauhan, A., Makharia, G.K. (2021). Epidemiology of celiac disease. In advances in celiac disease: Improving pediatric and adult care (pp. 7-22). Cham: Springer International Publishing.
- 7. Molder, A., Balaban, D.V., Jinga, M., Molder, C.C. (2020). Current evidence on computer-aided diagnosis of celiac disease: Systematic review. Frontiers in Pharmacology, 11, 341. [CrossRef]
- 8. Lerner, A., Jeremias, P., Matthias, T. (2015). The world incidence and prevalence of autoimmune diseases is increasing. International Journal of Celiac Disease, 3(4), 151-155. [CrossRef]
Ayrıntılar
Birincil Dil
İngilizce
Konular
Eczacılık İşletmeciliği
Bölüm
Araştırma Makalesi
Erken Görünüm Tarihi
29 Ağustos 2023
Yayımlanma Tarihi
20 Eylül 2023
Gönderilme Tarihi
21 Temmuz 2023
Kabul Tarihi
16 Ağustos 2023
Yayımlandığı Sayı
Yıl 2023 Cilt: 47 Sayı: 3
Cited By
Pharmacy practice and policy research in Türkiye: a systematic review of literature
Journal of Pharmaceutical Policy and Practice
https://doi.org/10.1080/20523211.2024.2385939